Abstract
Nucleic acids that can bind with high affinity and specificity to target molecules are called “aptamers”. Aptamers recognise a large variety of different enzymatic methods. molecule classes. The main focus of this chapter is small molecules as targets. Aptamers are applied complementarily to antibody technologies and can substitute antibodies or small molecules wherever their different properties, such as biochemical nature or highly discriminating capacities, are advantageous. Examples of promising applications of these versatile molecules are discussed in the field of therapeutics and biotechnology with a special view to small-molecule detection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahmed N, Thornalley PJ (2003) Quantitative screening of protein biomarkers of early glycation, advanced glycation, oxidation and nitrosation in cellular and extracellular proteins by tandem mass spectrometry multiple reaction monitoring. Biochem Soc Trans 31:1417–1422
Altria KD, Elder D (2004) Overview of the status and applications of capillary electrophoresis to the analysis of small molecules. J Chromatogr A 1023:1–14
Aurup H, Williams DM, Eckstein F (1992) 2′-Fluoro-and 2′-amino-2′-deoxynucleoside 5′-triphosphates as substrates for T7 RNA polymerase. Biochemistry 31:9636–9641
Baldrich E, Restrepo A, O’sullivan CK (2004) Aptasensor development: elucidation of critical parameters for optimal aptamer performance. Anal Chem 76:7053–7063
Bock LC, Griffin LC, Latham JA, Vermaas EH, Toole JJ (1992) Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 355:564–566
Breaker RR (2002) Engineered allosteric ribozymes as biosensor components. Curr Opin Biotechnol 13:31–39
Breaker RR (2004) Natural and engineered nucleic acids as tools to explore biology. Nature 432:838–845
Brody EN, Gold L (2000) Aptamers as therapeutic and diagnostic agents. J Biotechnol 74:5–13
Bruno JG, Kiel JL (2002) Use of magnetic beads in selection and detection of biotoxin aptamers by electrochemiluminescence and enzymatic methods. Biotechniques 32:178–80, 182–183
Burgstaller P, Jenne A, Blind M (2002) Aptamers and aptazymes: accelerating small molecule drug discovery. Curr Opin Drug Discov Devel 5:690–700
Chelliserrykattil J, Ellington AD (2004) Evolution of a T7 RNA polymerase variant that transcribes 2′-O-methyl RNA. Nat Biotechnol 22:1155–1160
Cicortas Gunnarsson L, Nordberg Karlsson E, Albrekt AS, Andersson M, Holst O, Ohlin M (2004) A carbohydrate binding module as a diversity-carrying scaffold. Protein Eng Des Sel 17:213–221
Clark SL, Remcho VT (2003) Electrochromatographic retention studies on a flavin-binding RNA aptamer sorbent. Anal Chem 75:5692–5696
Clegg RM (1995) Fluorescence resonance energy transfer. Curr Opin Biotechnol 6:103–110
Cox JC, Ellington AD (2001) Automated selection of anti-protein aptamers. Bioorg Med Chem 9:2525–2531
Cox JC, Hayhurst A, Hesselberth J, Bayer TS, Georgiou G, Ellington AD (2002) Automated selection of aptamers against protein targets translated in vitro: from gene to aptamer. Nucleic Acids Res 30:e108
Daniels DA, Sohal AK, Rees S, Grisshammer R (2002) Generation of RNA aptamers to the G-protein-coupled receptor for neurotensin, NTS-1. Anal Biochem 305:214–226
Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346:818–822
Eulberg D, Klussmann S (2003) Spiegelmers: biostable aptamers. Chembiochem 4:979–983
Eyetech Study Group (2002) Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration. Retina 22:143–152
Famulok M (1999) Oligonucleotide aptamers that recognize small molecules. Curr Opin Struct Biol 9:324–329
Famulok M, Mayer G (1999) Aptamers as tools inmolecular biology and immunology. Curr Top Microbiol Immunol 243:123–136
Famulok M, Verma S (2002) In vivo-applied functional RNAs as tools in proteomics and genomics research. Trends Biotechnol 20:462–466
Famulok M, Blind M, Mayer G (2001) Intramers as promising new tools in functional proteomics. Chem Biol 8:931–939
Fedor MJ (2002) The role of metal ions in RNA catalysis. Curr Opin Struct Biol 12:289–295
Glokler J, Angenendt P (2003) Protein and antibody microarray technology. J Chromatogr B Analyt Technol Biomed Life Sci 797:229–240
Gold L, Polisky B, Uhlenbeck O, Yarus M (1995) Diversity of oligonucleotide functions. Annu Rev Biochem 64:763–797
Good PD, Krikos AJ, Li SX, Bertrand E, Lee NS, Giver L, Ellington A, Zaia JA, Rossi JJ, Engelke DR (1997) Expression of small, therapeutic RNAs in human cell nuclei. Gene Ther 4:45–54
Grate D, Wilson C (2001) Inducible regulation of the S. cerevisiae cell cycle mediated by an RNA aptamer-ligand complex. Bioorg Med Chem 9:2565–2570
Griffin LC, Tidmarsh GF, Bock LC, Toole JJ, Leung LL (1993) In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits. Blood 81:3271–3276
Hanna R, Doudna JA (2000) Metal ions in ribozyme folding and catalysis. Curr Opin Chem Biol 4:166–170
Hentze MW, Kuhn LC (1996) Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci USA 93:8175–8182
Hermann T, Patel DJ (2000) Adaptive recognition by nucleic acid aptamers. Science 287:820–825
Hewitt CJ, Nebe-Von-Caron G (2004) The application of multi-parameter flow cytometry to monitor individual microbial cell physiological state. Adv Biochem Eng Biotechnol 89:197–223
Homann M, Goringer HU (2001) Uptake and intracellular transport of RNA aptamers in African trypanosomes suggest therapeutic “piggy-back” approach. Bioorg Med Chem 9:2571–2580
Inaba Y, Hamada-Sato N, Kobayashi T, Imada C, Watanabe E (2003) Determination of D-and L-alanine concentrations using a pyruvic acid sensor. Biosens Bioelectron 18:963–971
Iyo M, Kawasaki H, Taira K (2002) Allosterically controllable maxizymes for molecular gene therapy. Curr Opin Mol Ther 4:154–165
Jayasena SD (1999) Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem 45:1628–1650
Jellinek D, Green LS, Bell C, Lynott CK, Gill N, Vargeese C, Kirschenheuter G, McGee DP, Abesinghe P, Pieken WA, et al (1995) Potent 2′-amino-2′-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor. Biochemistry 34:11363–11372
Kawakami J, Imanaka H, Yokota Y, Sugimoto N (2000) In vitro selection of aptamers that act with Zn2+. J Inorg Biochem 82:197–206
Kim SJ, Kim MY, Lee JH, You JC, Jeong S (2002) Selection and stabilization of the RNA aptamers against the human immunodeficiency virus type-1 nucleocapsid protein. Biochem Biophys Res Commun 291:925–931
Klussmann S, Nolte A, Bald R, Erdmann VA, Furste JP (1996) Mirror-image RNA that binds D-adenosine. Nat Biotechnol 14:1112–1115
Koizumi M, Breaker RR (2000) Molecular recognition of cAMP by an RNA aptamer. Biochemistry 39:8983–8992
Kubodera T, Watanabe M, Yoshiuchi K, Yamashita N, Nishimura A, Nakai S, Gomi K, Hanamoto H (2003) Thiamine-regulated gene expression of Aspergillus oryzae thiA requires splicing of the intron containing a riboswitch-like domain in the 5′-UTR. FEBS Lett 555:516–520
Lorsch JR, Szostak JW (1994) In vitro selection of RNA aptamers specific for cyanocobalamin. Biochemistry 33:973–982
Lottspeich F, Zorbos H (1998) Bioanalytik. Spektrum Akad. Verlag, Heidelberg, Berlin, New York, pp 9–463
Lutz R, Bujard H (1997) Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1–I2 regulatory elements. Nucleic Acids Res 25:1203–1210
Meis JE, Chen F (2002) In vitro synthesis of 2′-fluoro-modified RNA transcripts that are completely resistant to RNase A digestion using the DuraScribe ™T7 transcription kit. Epicentre Forum 9:10–11
Menger M, Tuschl T, Eckstein F, Porschke D (1996) Mg(2+)-dependent conformational changes in the hammerhead ribozyme. Biochemistry 35:14710–14716
Nicholls H (2003) Improving drug response with pharmacogenomics. Drug Discov Today 8:281–282
Nimjee SM, Rusconi CP, Sullenger BA (2005) APTAMERS: An Emerging Class of Therapeutics. Annu Rev Med 56:555–583
Nix J, Sussman D, Wilson C (2000) The 1.3 A crystal structure of a biotin-binding pseudoknot and the basis for RNA molecular recognition. J Mol Biol 296:1235–1244
Nonin-Lecomte S, Lin CH, Patel DJ (2001) Additional hydrogen bonds and base-pair kinetics in the symmetrical AMP-DNA aptamer complex. Biophys J 81:3422–3431
O’sullivan CK (2001) Aptasensors—the future of biosensing? Anal Bioanal Chem 372:44–48
Ooms M, Huthoff H, Russell R, Liang C, Berkhout B (2004) A riboswitch regulates RNA dimerization and packaging in human immunodeficiency virus type 1 virions. J Virol 78:10814–10819
Patel DJ (1997) Structural analysis of nucleic acid aptamers. Curr Opin Chem Biol 1:32–46
Pieken WA, Olsen DB, Benseler F, Aurup H, Eckstein F (1991) Kinetic characterization of ribonuclease-resistant 2′-modified hammerhead ribozymes. Science 253:314–317
Rajendran M, Ellington AD (2002) Selecting nucleic acids for biosensor applications. Comb Chem High Throughput Screen 5:263–270
Rimmele M (2003) Nucleic acid aptamers as tools and drugs: recent developments. Chembiochem 4:963–971
Rimmele M, Ehrentreich-Förster E (2004) Nukleinsäuren als biochemische Fängermoleküle. BIOforum 04:68–69
Roychowdhury-Saha M, Lato SM, Shank ED, Burke DH(2002) Flavin recognition by an RNA aptamer targeted toward FAD. Biochemistry 41:2492–2499
Rubin B, Sonderstrup G (2004) Citrullination of self-proteins and autoimmunity. Scand J Immunol 60:112–120
Ruckman J, Green LS, Beeson J, Waugh S, Gillette WL, Henninger DD, Claesson-Welsh L, Janjic N (1998) 2′-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J Biol Chem 273:20556–20567
Rusconi CP, Scardino E, Layzer J, Pitoc GA, Ortel TL, Monroe D, Sullenger BA (2002) RNA aptamers as reversible antagonists of coagulation factor IXa. Nature 419:90–94
Rusconi CP, Roberts JD, Pitoc GA, Nimjee SM, White RR, Quick G Jr, Scardino E, Fay WP, Sullenger BA (2004) Antidote-mediated control of an anticoagulant aptamer in vivo. Nat Biotechnol 22:1423–1428
Sousa R, Padilla R (1995) A mutant T7 RNA polymerase as a DNA polymerase. EMBO J 14:4609–4621
Sudarsan N, Barrick JE, Breaker RR (2003) Metabolite-binding RNA domains are present in the genes of eukaryotes. RNA 9:644–647
Suess B, Fink B, Berens C, Stentz R, Hillen W (2004) A theophylline responsive riboswitch based on helix slipping controls gene expression in vivo. Nucleic Acids Res 32:1610–1614
Sun S (2000) Technology evaluation: SELEX, Gilead Sciences Inc. Curr Opin Mol Ther 2:100–105
Sussman D, Greensides D, Reilly K, Wilson C (1999) Preliminary characterization of crystals of an in vitro evolved cyanocobalamin (vitamin B12) binding RNA. Acta Crystallogr D Biol Crystallogr 55:326–328
Szabo A, Stolz L, Granzow R (1995) Surface plasmon resonance and its use in biomolecular interaction analysis (BIA). Curr Opin Struct Biol 5:699–705
Toulme JJ, Di Primo C, Boucard D (2004) Regulating eukaryotic gene expression with aptamers. FEBS Lett 567:55–62
Tucker CE, Chen LS, Judkins MB, Farmer JA, Gill SC, Drolet DW (1999) Detection and plasma pharmacokinetics of an anti-vascular endothelial growth factor oligonucleotide-aptamer (NX1838) in rhesus monkeys. J Chromatogr B Biomed Sci Appl 732:203–212
Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505–510
Ulrich H, Magdesian MH, Alves MJ, Colli W (2002) In vitro selection of RNA aptamers that bind to cell adhesion receptors of Trypanosoma cruzi and inhibit cell invasion. J Biol Chem 277:20756–20762
Vinores SA (2003) Technology evaluation: pegaptanib, Eyetech/Pfizer. Curr Opin Mol Ther 5:673–679
Vogt M, Skerra A (2004) Construction of an artificial receptor protein (“anticalin”) based on the human apolipoprotein D. Chembiochem 5:191–199
Vuyisich M, Beal PA (2002) Controlling protein activity with ligand-regulated RNA aptamers. Chem Biol 9:907–913
Walter G, Bussow K, Lueking A, Glokler J (2002) High-throughput protein arrays: prospects for molecular diagnostics. Trends Mol Med 8:250–253
Wang C, Zhang M, Yang G, Zhang D, Ding H, Wang H, Fan M, Shen B, Shao N (2003) Single-stranded DNA aptamers that bind differentiated but not parental cells: subtractive systematic evolution of ligands by exponential enrichment. J Biotechnol 102:15–22
White R, Rusconi C, Scardino E, Wolberg A, Lawson J, Hoffman M, Sullenger B (2001) Generation of species cross-reactive aptamers using “toggle” SELEX. Mol Ther 4:567–573
White RR, Sullenger BA, Rusconi CP (2000) Developing aptamers into therapeutics. J Clin Invest 106:929–934
Wibrand F (2004) A microplate-based enzymatic assay for the simultaneous determination of phenylalanine and tyrosine in serum. Clin Chim Acta 347:89–96
Wilson C, Nix J, Szostak J (1998) Functional requirements for specific ligand recognition by a biotin-binding RNA pseudoknot. Biochemistry 37:14410–14419
Wilson DS, Szostak JW (1999) In vitro selection of functional nucleic acids. Annu Rev Biochem 68:611–647
Winkler WC, Cohen-Chalamish S, Breaker RR (2002) An mRNA structure that controls gene expression by binding FMN. Proc Natl Acad Sci USA 99:15908–15913
Woodbury CP Jr, Venton DL (1999) Methods of screening combinatorial libraries using immobilized or restrained receptors. J Chromatogr B Biomed Sci Appl 725:113–137
Zaydan R, Dion M, Boujtita M (2004) Development of a new method, based on a bioreactor coupled with an L-lactate biosensor, toward the determination of a nonspecific inhibition of L-lactic acid production during milk fermentation. J Agric Food Chem 52:8–14
Zhang Z, Blank M, Schluesener HJ (2004) Nucleic acid aptamers in human viral disease. Arch Immunol Ther Exp (Warsz) 52:307–315
Zhu H, Snyder M (2003) Protein chip technology. Curr Opin Chem Biol 7:55–63
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Menger, M., Glökler, J., Rimmele, M. (2006). Application of Aptamers in Therapeutics and for Small-Molecule Detection. In: Erdmann, V., Barciszewski, J., Brosius, J. (eds) RNA Towards Medicine. Handbook of Experimental Pharmacology, vol 173. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27262-3_18
Download citation
DOI: https://doi.org/10.1007/3-540-27262-3_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-27261-8
Online ISBN: 978-3-540-27262-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)